Related Experiment Video
Updated: Aug 7, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis
Yiping Weng1,2, Weihao Duan2, Xuecheng Yu2
1State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Abstract:
Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)-324-3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplored. In this study, miR-324-3p expression was markedly reduced in OS cell lines and tissues. Functionally, miR-324-3p overexpression suppressed OS progression and was involved in the Warburg effect. Mechanistically, miR-324-3p negatively regulated phosphoglycerate mutase 1 (PGAM1) expression by targeting its 3'-UTR. Moreover, high expression of PGAM1 promoted OS progression and aerobic glycolysis, which were associated with inferior overall survival in patients with OS. Notably, the tumor suppressor functions of miR-324-3p were partially recovered by PGAM1 overexpression. In summary, the miR-324-3p/PGAM1 axis plays an important role in regulating OS progression by controlling the Warburg effect. Our results provide mechanistic insights into the function of miR-324-3p in glucose metabolism and subsequently on the progression of OS. Targeting the miR-324-3p/PGAM1 axis could be a promising molecular strategy for the treatment of OS.
Insights
MicroRNA-324-3p suppresses osteosarcoma progression by inhibiting the Warburg effect. This microRNA targets PGAM1, offering a potential therapeutic strategy for bone cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma (OS) is a primary bone cancer with limited treatment options.
- MicroRNA (miR)-324-3p's role in OS progression and its mechanisms are largely unknown.
- The Warburg effect, altered glucose metabolism, is implicated in cancer development.
Purpose of the Study:
- To investigate the biological roles and mechanisms of miR-324-3p in osteosarcoma progression.
- To explore the relationship between miR-324-3p, PGAM1, and the Warburg effect in OS.
- To evaluate the therapeutic potential of targeting the miR-324-3p/PGAM1 axis.
Main Methods:
- Assessed miR-324-3p expression in OS cell lines and tissues.
- Overexpressed miR-324-3p to evaluate its functional impact on OS progression and the Warburg effect.
- Identified PGAM1 as a direct target of miR-324-3p using 3'-UTR analysis.
- Correlated PGAM1 expression with OS progression, aerobic glycolysis, and patient survival.
Main Results:
- miR-324-3p expression was significantly reduced in OS.
- Overexpression of miR-324-3p inhibited OS cell proliferation and migration, and reduced aerobic glycolysis.
- miR-324-3p directly targeted and downregulated PGAM1 expression.
- High PGAM1 expression promoted OS progression and aerobic glycolysis, correlating with poor patient survival.
- PGAM1 overexpression partially rescued the tumor-suppressive effects of miR-324-3p.
Conclusions:
- The miR-324-3p/PGAM1 axis is a critical regulator of osteosarcoma progression via modulation of the Warburg effect.
- miR-324-3p acts as a tumor suppressor by inhibiting aerobic glycolysis in OS.
- Targeting the miR-324-3p/PGAM1 pathway presents a promising molecular strategy for osteosarcoma treatment.
More Related Videos
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway

